Improving Client Performance, Outcomes, and Impacts™
Market Entry | Market Penetration | Market Leadership
- Founded in 1988, the xIQ Family of Companies helps social-benefit startups, small-to-midsized businesses (SMBs), and world-class multinational corporations (MNCs) create radically innovative and highly profitable minimum viable markets (MVMs), minimum viable corporations (MVCs), and minimum viable products (MVPs)—so they can favorably transform the U.S. healthcare, education, and social-services sectors.
- Our C-Suite business strategists, program directors, and content producers work with social-benefit engineers, conscious capitalists, and chief officers to help their mission-driven enterprises with U.S. market entry, market penetration, and market leadership.
- Our third-generation research, education, and consulting unit (Central IQ, Inc.) delivers market, corporate, and product development services that improve client revenues, operating efficiencies, and earnings growth.
- Our approach is unique in applying the socially responsible, future-creating principles and practices of Peter F. Drucker to today’s most intractable challenges—so-called Wicked Problems.
- Focused on real-world performance, outcomes, and impacts; we help innovators, entrepreneurs, and executives promote breakthroughs, best practices, and benchmarks that improve the well-being, productive capacity, and socioeconomic status of individuals, organizations, and communities.
- Our radically effective analytical, strategic, and hands-on support services are essential for result-minded innovators, entrepreneurs, and executives facing the volume-to-value (V2V) transition and increasingly intense demands for value-based healthcare (VBHC), value-based education (VBE), and value-based social services (VBSS).
- What differentiates our pioneering clients from others in the industry is their willingness to be held entirely accountable for the performance, outcomes, and impacts of their products, services, and solutions.
- These clients are “good actors” who welcome real-world data (RWD) and real-world evidence (RWE) collaborations, value-based contracts (VBC) (such as pay-for-performance [P4P], value-based payment [VBP], and outcomes-based compensation [OBC] agreements), and social-impact funding.
- They see value delivery as a way to legitimately improve revenues, operating efficiencies, and earnings growth as the U.S. healthcare, education, and social-service sectors transition from volume-based business models to value-based business models.
- They contribute to a better-functioning society by delivering real-world results (RWRs) that help individuals, organizations, and communities flourish.
- They seek our help in C-Suite initiatives ranging from product portfolio evaluations (that address new value imperatives) to post-market surveillance programs (focused on real-world insights [RWIs] and [real-world results]).
- With our support, their products, services, and solutions become the new gold standards for real-world value (RWV).
- In the U.S. healthcare sector, Central IQ and the xIQ Family of Companies are best known for our market access, market messaging, and market engagement programs that lead to widespread insurance coverage, unique insurance billing codes, favorable insurance reimbursement, real-world data (RWD) and real-world evidence (RWE) collaborations, value-based contracts (VBC) (such as pay-for-performance [P4P], value-based payment [VBP], and outcomes-based compensation [OBC] agreements), and social-impact funding.
- Our longstanding team members and strategic allies provide (1) outcomes-accountable patient support services (aka hub services); (2) social-listening, strategic-messaging, and plain-language editing services; and (3) ethical and state-of-the-art network and influence analytics for next-generation key opinion leader (KOL) mapping (covering health science, social science, and data science KOLs).
- Our extended team also provides longitudinal claims analytics across multiple years and 305+ million lives to help (1) evaluate client products, services, and solutions in real-world settings; (2) contribute to increasingly compelling value dossiers for U.S.-based health technology assessment (HTA) authorities; and (3) build competencies around Food and Drug Administration (FDA), Centers for Medicare and Medicaid Services (CMS), and Agency for Healthcare Research and Quality (AHRQ) guidelines for real-world data (RWD) and real-world evidence (RWE).
- If you’re an innovator, entrepreneur, or executive who is tracking the volume-to-value (V2V) transition and who wants targeted expertise in value-based markets (VBMs), then contact us.
- We’ll deliver the analytics, strategy, and support services you need to lead the field.
Rethink market, corporate, and product development
- Create scalable, sustainable, and high-value business models to achieve favorable individual, organizational, and community results.
- Tie compensation to “greater good” endpoints and lead the volume-to-value (V2V) transition.
- Scale solutions across targeted health plans, beneficiary subpopulations, and sites of service.
- Assure access to high-quality, cost-effective care for appropriate covered lives in appropriate settings at appropriate times.
- Compile real-world data (RWD) and real-world evidence (RWE) through next-gen access, hub, and wraparound (AHW) services.
- Reduce the incidence, prevalence, and cost of targeted diseases, comorbidities, and complications.
Improve performance, outcomes, and impacts
- Improve economic, clinical, and humanistic outcomes (ECHOs).
- Achieve the Triple/Quadruple/Quintuple Aim endpoints of reduced per capita costs, improved population health, enhanced patient and provider experiences, and broadened health equity.
- Support the United Nations’ Sustainable Development Goals, especially SDG #3: Health.
- Support World Health Organization (WHO) priorities, programs, and practices.
- Enhance the well-being, productive capacity, and socioeconomic status of individuals, organizations, and communities.
- Enable sustainable and increasingly broad-based human flourishing, contributions, and socioeconomic lift—and contribute to a better functioning U.S. and global society.
Lead the Volume-to-Value Transition
Analytics, Strategy, and Support Services
IHA
The Institute for Healthcare Advancement (IHA) is a not-for-profit, 501(c)(3) public benefit charity that empowers programs, professionals, and patients to achieve better health outcomes. Targeting systemic barriers to empowerment, IHA facilitates and promotes breakthroughs and best practices that favorably influence social determinants of health (SDoHs), especially health literacy. Within the health, education, and social services sectors, IHA produces content, convenings, and commercialization opportunities for plain language solutions at the level of community care, healthcare, and self-care. IHA’s ultimate goals are to (1) remove barriers to health equity; (2) promote culturally competent care; and (3) enhance the well-being, productive capacity, and socioeconomic status of individuals, organizations, and communities in the U.S. and abroad.
Central IQ, Inc.
Central IQ is a research, education, and consulting firm that delivers market, corporate, and product development services to help innovators, entrepreneurs, and executives jumpstart revenues, operating efficiencies, and earnings growth in the healthcare, education, and social-services sectors around breakthroughs, best practices, and benchmarks that improve the well-being, productive capacity, and socioeconomic status of individuals, organizations, and communities.
SYFR
SYFR Health Information Management is a strategic revenue cycle management firm that works with providers pushing the edge of their specialties. By understanding key revenue drivers and obstacles in healthcare, SYFR reduces time-consuming and costly activities that plague those dependent on medical billing, coding, and payment precedents. With knowledge of value-based contracting, evidence-based coding, and impact-accountable billing, SYFR is leading the field in outcomes-based compensation (OBC).
Reimbursement IQ
Reimbursement IQ—and our allies at Central IQ, Value-Based Strategies, Value Vitals, PRO-Spectus, and NAMSA—provide analytical, strategic, and hands-on support services that reduce the incidence, prevalence, and cost of diseases and other health-related conditions by (1) collecting real-world data (RWD) and building real-world evidence (RWE) through access, hub, and wraparound (AHW) solutions (so patients benefit more fully from the healthcare industry’s most safe, effective, and cost-saving products, services, and solutions); (2) documenting improved economic, clinical, and humanistic outcomes (ECHOs) and Triple/Quadruple/Quintuple Aim successes to elicit evidence-based coverage, coding, and payment policies from health plan purchasers, third-party payers (TPPs) and third-party administrators (TPAs), and capitated healthcare providers; and (3) facilitating value-based contracts (VBC) (such as pay-for-performance [P4P], value-based payment [VBP], and outcomes-based compensation [OBC] agreements), and social-impact funding.
Impact Analytica
Impact Analytica is data science, health science, and social science research, education, and consulting firm—owned by Central IQ—that delivers real-world insight so life science decision-makers, content developers, and practice drivers can properly educate, engage, and empower socially responsible policymakers, peer influencers, and practitioners.
We compile real-world evidence (RWE) of value, including the Triple/Quadruple/Quintuple Aim endpoints of reduced per capita costs, improved population health, enhanced patient and provider experiences, and broadened health equity. We provide advanced analytics, visualization platforms, and support services to help deserving industry pioneers and market leaders put critical insight into practice in ethical ways. We ensure that legitimate medical breakthroughs, best practices, and benchmarks can more rapidly reduce the incidence, prevalence, and cost of diseases and other adverse conditions.